BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen L, Huang W, Wang L, Zhang Z, Zhang F, Zheng S, Kong D. The effects of epigenetic modification on the occurrence and progression of liver diseases and the involved mechanism. Expert Rev Gastroenterol Hepatol 2020;14:259-70. [PMID: 32124651 DOI: 10.1080/17474124.2020.1736042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Li S, Song Z, Yao P, Qin J. Editorial: Alcohol Consumption and Liver Diseases: From Pathology to Phytotherapy. Front Pharmacol 2022;13:848334. [DOI: 10.3389/fphar.2022.848334] [Reference Citation Analysis]
2 Cai Q, Gan C, Tang C, Wu H, Gao J. Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease. Front Pharmacol 2021;12:784591. [PMID: 34887768 DOI: 10.3389/fphar.2021.784591] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Czaja AJ. Epigenetic Aspects and Prospects in Autoimmune Hepatitis. Front Immunol 2022;13:921765. [DOI: 10.3389/fimmu.2022.921765] [Reference Citation Analysis]
4 Johnson ND, Wu X, Still CD, Chu X, Petrick AT, Gerhard GS, Conneely KN, DiStefano JK. Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD. Clin Epigenetics 2021;13:152. [PMID: 34353365 DOI: 10.1186/s13148-021-01129-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wajsbrot NB, Leite NC, Salles GF, Villela-Nogueira CA. Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring. World J Gastroenterol 2022; 28(25): 2890-2899 [DOI: 10.3748/wjg.v28.i25.2890] [Reference Citation Analysis]